Matinas BioPharma Holdings, Inc. (MTNB) Key Statistics & Financial Ratios

Matinas BioPharma Holdings, Inc. (MTNB) — Price $0.17 — Healthcare — Biotechnology — AMEX

Latest reported results:

Key statistics dashboard for Matinas BioPharma Holdings, Inc. (MTNB). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.

Matinas BioPharma Holdings, Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to identifying and advancing a range of potential therapeutic products. The company's innovative Lipid Nanocrystal (LNC) platform technology underpins its product development efforts.

Stock Data

Price$0.17
Market Cap$1M
Enterprise Value$302662
Beta1.40
ExchangeAMEX
CountryUS

Valuation Multiples

P/E Ratio-0.13
Price / Book0.57
P/S0.00
EV/EBITDA-0.05
EV/Sales0.00
EV/FCF-0.05
P/FCF-0.16
Earnings Yield-691.05%
FCF Yield-607.00%
Dividend Yield0.00%

Profitability

Gross Margin0.00%
EBIT Margin0.00%
EBITDA Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Return on Equity-181.45%
Return on Assets-214.21%
Return on Invested Capital-323.22%
Return on Capital Employed-323.38%

Financial Health

Current Ratio0.85
Quick Ratio0.85
Cash Ratio0.56
Debt / Equity0.00
Debt / Assets0.18%
Net Debt / EBITDA0.12
Interest Coverage0.00
Piotroski F-Score2
Altman Z-Score-42.88

Per-Share Data

Revenue per share0.00
Book Value per share0.28
Cash per share0.12
FCF per share-1.00
Tangible Book Value per share-0.07
Dividend per share0.00

Analyst Consensus

Strong Buy0
Buy7
Hold1
Sell0
Strong Sell0
Total analysts8
Avg rating (1-5)0.88

Related companies: ACXP · ADIL · ADXN · BCLI · CDIO · HCWB · IBO

Explore sector: Healthcare · Biotechnology

More sections of MTNB: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events

Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks